In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions. (2022)
Attributed to:
Inquire: Software for real-time analysis of binding
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jmgm.2022.108231
PubMed Identifier: 35667143
Publication URI: http://europepmc.org/abstract/MED/35667143
Type: Journal Article/Review
Volume: 115
Parent Publication: Journal of molecular graphics & modelling
ISSN: 1093-3263